KJIM :: Korean Journal of Internal Medicine

Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores

A comparative retrospective study of pre-fibrotic primary myelofibrosis versus overtly fibrotic stage in Qatar: clinicopathological, genetic landscape, risk stratification and survival data (2008–2021) – a single cente

Sarah A. ElKourashy, Dina Soliman, Abdelfatteh El Omri, Ruba Y. Taha, Hesham Elsabah, Hind Alashi, Prem Chandra, Halima El Omri

Pelabresib (CPI-0610): An Exciting Novel Drug for the Treatment of Myelofibrosis

Current Hematologic Malignancy Reports.2023; 18(4): 113. CrossRef

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice

Shanti Amé, Fiorenza Barraco, Jean‐Christophe Ianotto, Eric Jourdan, Jérôme Rey, Jean‐François Viallard, Mathieu Wémeau, Jean‐Jacques Kiladjian

JAK2 inhibitors for the treatment of Philadelphia-negative myeloproliferative neoplasms: current status and future directions

Xiaofeng Liu, Binyou Wang, Yuan Liu, Yang Yu, Ying Wan, Jianming Wu, Yiwei Wang

Thrombembolic Events - A Predictive Factor in Primary Myelofibrosis. A Case Report and a Short Review of the Literature

Lucretia Anghel, Liliana Baroiu, Ioana Anca Stefanopol, Camelia Busila, Daniela Mariana Ignat

Ruxolitinib and tuberculosis: A case report with brief review

Neema Tiwari, Aparajita Singh, Bhupendra Singh, Shailendra Prasad Verma, Anil Kumar Tripathi

Indian Journal of Tuberculosis.2022; 69(3): 354. CrossRef

Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 – 100 × 109/L): Final Analysis of an Open-Label Phase 2 Study

Moshe Talpaz, Josef Prchal, Lawrence Afrin, Murat Arcasoy, Solomon Hamburg, Jason Clark, Deanna Kornacki, Philomena Colucci, Srdan Verstovsek

Clinical Lymphoma Myeloma and Leukemia.2022; 22(5): 336. CrossRef

A Case of Primary Myelofibrosis With Transformation to Leukemia Cutis

Jasmine Saleh, Aayushma Regmi, Jodi J. Speiser, Kumaran M. Mudaliar, Reeba Omman, Milind Velankar, Kamran M. Mirza

The American Journal of Dermatopathology.2022; 44(1): 58. CrossRef

IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis

Arcangelo Liso, Santina Venuto, Anna Rita Daniela Coda, Cesarina Giallongo, Giuseppe Alberto Palumbo, Daniele Tibullo

International Journal of Molecular Sciences.2022; 23(8): 4358. CrossRef

The Manifestation of a Patient With Myelofibrosis in 68Ga-DOTA-FAPI-04 PET/CT Mimicking “Super Bone Imaging”

Xue Li, Qian Zhao, Qianfeng Luo, Liming Chen, Zhanwen Huang

Clinical Nuclear Medicine.2022; 47(12): 1056. CrossRef

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms

Jinyong Kim, Ja Min Byun, Junshik Hong, Youngil Koh, Dong-Yeop Shin, Inho Kim, Sung-Soo Yoon, Hyunkyung Park, Soo-Mee Bang

IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis

Lucia Longhitano, Daniele Tibullo, Nunzio Vicario, Cesarina Giallongo, Enrico La Spina, Alessandra Romano, Sofia Lombardo, Marina Moretti, Francesco Masia, Anna Rita Daniela Coda, Santina Venuto, Paolo Fontana, Rosalba Parenti, Giovanni Li Volti, Michelin

Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis

Franco Castillo-Tokumori, Chetasi Talati, Najla Al Ali, David Sallman, Seongseok Yun, Kendra Sweet, Eric Padron, Jeffrey Lancet, Rami Komrokji, Andrew T. Kuykendall

Clinical Lymphoma Myeloma and Leukemia.2020; 20(12): e956. CrossRef

Primary myelofibrosis with concurrent CALR and MPL mutations: A case report

Feng-Ping Zhou, Cheng-Cheng Wang, Hua-Ping Du, Shan-Bo Cao, Jin Zhang

World Journal of Clinical Cases.2020; 8(22): 5618. CrossRef

Janus kinase V617F mutation detection in patients with myelofibrosis

D Nikolova, A Yordanov, V Damyanova, A Radinov, D Toncheva

Balkan Journal of Medical Genetics.2019; 22(1): 57. CrossRef

Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking

Jie Li, Xiaoran Ma, Cun Liu, Huayao Li, Jing Zhuang, Chundi Gao, Chao Zhou, Lijuan Liu, Kejia Wang, Changgang Sun, Takao Namiki

Evidence-Based Complementary and Alternative Medicine.2018;[Epub] CrossRef